#retatrutide
4 articles tagged with #retatrutide
Retatrutide — Tinjauan Riset Agonis Tripel GLP-1/GIP/Glukagon
Retatrutide adalah agonis tripel pertama untuk reseptor GLP-1, GIP, dan glukagon yang memasuki riset incretin utama. Tinjauan ini membahas mekanismenya — apa yang dikontribusikan setiap lengan reseptor, mengapa aktivasi reseptor glukagon penting, dan bagaimana profil reseptor-tripel dibandingkan dengan senyawa dual-incretin.
Retatrutide — Triple GLP-1/GIP/Glucagon Agonist Research Review
Retatrutide is the first triple agonist of GLP-1, GIP, and glucagon receptors to enter major incretin research. This review walks through its mechanism — what each receptor arm contributes, why glucagon-receptor activation matters, and how the triple-receptor profile compares to dual-incretin compounds.
Riset Incretin GLP-1 — Semaglutide, Tirzepatide, Retatrutide Dibandingkan
Perbandingan farmakologi reseptor untuk tiga peptide incretin riset utama: Semaglutide (agonis GLP-1 tunggal), Tirzepatide (co-agonis ganda GIP/GLP-1), dan Retatrutide (agonis tripel GLP-1/GIP/glukagon). Apa yang ditambahkan setiap reseptor ke profil metabolik.
GLP-1 Incretin Research — Semaglutide, Tirzepatide, Retatrutide Compared
A receptor-pharmacology comparison of the three flagship incretin research peptides: Semaglutide (single GLP-1 agonist), Tirzepatide (dual GIP/GLP-1 co-agonist), and Retatrutide (triple GLP-1/GIP/glucagon agonist). What each receptor adds to the metabolic profile.